Public Profile

Laboratoires Servier

Laboratoires Servier, a prominent French pharmaceutical company, is headquartered in Suresnes, France. Founded in 1954, Servier has established itself as a key player in the global healthcare industry, with a strong presence in Europe, Asia, and Africa. The company focuses on innovative treatments in various therapeutic areas, including cardiology, diabetes, oncology, and neurology. Servier is renowned for its commitment to research and development, investing significantly in new drug discovery and development. Its core products, such as the antihypertensive medication Perindopril, exemplify the company's dedication to improving patient outcomes through unique formulations and comprehensive treatment solutions. With a robust portfolio and a reputation for quality, Laboratoires Servier continues to strengthen its market position, achieving notable milestones in both innovation and patient care.

DitchCarbon Score

How does Laboratoires Servier's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

57

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

30

Industry Benchmark

Laboratoires Servier's score of 57 is higher than 93% of the industry. This can give you a sense of how well the company is doing compared to its peers.

93%

Let us know if this data was useful to you

Laboratoires Servier's reported carbon emissions

In 2023, Laboratoires Servier reported total greenhouse gas emissions of approximately 102,991,000 kg CO2e, comprising 71,457,000 kg CO2e from Scope 1 and 36,432,000 kg CO2e from Scope 2. The company has set ambitious climate commitments, aiming to reduce absolute Scope 1 and 2 emissions by 25% by 2030, using 2016 as the base year. Additionally, Servier targets a 25% reduction in Scope 3 emissions from capital goods, waste generated in operations, business travel, and employee commuting, as well as a 21% reduction in Scope 3 emissions from downstream transportation and distribution by the same year. In 2022, Servier's total emissions were approximately 1,170,000,000 kg CO2e, with Scope 1 emissions at 79,432,000 kg CO2e and Scope 2 at 39,754,000 kg CO2e. The company has also committed to ensuring that key suppliers, representing 52% of emissions from purchased goods and services, will establish science-based targets for Scope 1 and 2 emissions by 2024. Overall, Servier's climate strategy reflects a strong commitment to reducing its carbon footprint and aligning with industry standards for sustainability.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

2016201920202021202220232024
Scope 1
62,044,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
Scope 2
54,578,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
Scope 3
-
0,000,000,000
-
-
0,000,000,000
-
-

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Laboratoires Servier's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Laboratoires Servier is in FR, which has a very low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Laboratoires Servier is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Pfizer Limited

IN
Pharmaceutical Preparation Manufacturing
Updated about 12 hours ago

Teva Pharmaceuticals

IL
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

Biofarm S.A.

RO
Pharmaceutical Preparation Manufacturing
Updated 4 days ago

Johnson And Johnson

US
Pharmaceutical Preparation Manufacturing
Updated 4 days ago

VIVUS, Inc.

US
Pharmaceutical Preparation Manufacturing
Updated 4 days ago

Sanofi

FR
Pharmaceutical Preparation Manufacturing
Updated 4 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers